Last Updated On 3/29/2024 2:26:07 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Novocure |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: Boston Scientific-US |
| Recipient: You |
| Company: Daiichi Sankyo/UCB Japan |
| Recipient: Your Institution |
|
| Consulting or Advisory Role |
| Company: Novocure |
| Recipient: You |
| Company: Novocure |
| Recipient: You |
| Company: Novocure |
| Recipient: You |
| Company: Novocure |
| Recipient: You |
| Company: Boston Scientific-US |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Novocure |
| Recipient: You |
| Company: Intima Biosciences |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: GlaxoSmithKline |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| Company: Minnetronix |
| Recipient: You |
| Company: Nomocan Pharmaceuticals |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|